Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **gastrointestinal mucosa** is a complex mucous membrane layer lining the digestive tract, composed of epithelial cells, connective tissue, and smooth muscle, responsible for absorption, secretion, and barrier functions[5][6]. **Mucoproteins** (primarily mucins such as MUC2) are highly glycosylated proteins secreted by goblet cells that form the structural framework of the mucus layer, providing a crucial barrier to pathogens, physical injury, and facilitating lubrication[2][3][4][6][7]. The mucus and underlying mucosa play essential roles in immune defense, maintaining a beneficial microbiome, and are implicated in diseases such as inflammatory bowel disease, infections, cancer, and disorders linked to mucosal barrier dysfunction[1][3][5][6]. While drugs like mucolytics can modify mucus properties, "gastrointestinal mucosa and mucoproteins" does not designate a unique molecular therapeutic target but a larger protective system within the GI tract.
Mucolytics: reduce mucus viscosity by breaking disulfide bonds in mucoproteins\nPeptide mucolytics: depolymerize DNA/F-actin in hypersecreted mucus (less direct on mucoproteins)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal mucosa and mucoproteins.